Fred Volkmar is professor of child psychiatry, pediatrics and psychology at the Yale Child Study Center.
Fred Volkmar
Professor
Yale Child Study Center
From this contributor
Narrowing of ‘autism’ in DSM-5 runs counter to idea of broad spectrum
The strict definition of autism in the latest version of the diagnostic manual is antithetical to the idea that autism comes in a wide variety of forms.
Narrowing of ‘autism’ in DSM-5 runs counter to idea of broad spectrum
Fred Volkmar: A decades-long perspective on autism research
Over the past 30 years, autism research pioneer Fred Volkmar says he has learned that researchers should be humble when assigning meaning to autism behavior, and seek to translate their findings into useful applications.
Fred Volkmar: A decades-long perspective on autism research
Explore more from The Transmitter
Exclusive: Brain and spinal cord institute halts research, citing funding problems
The Burke Neurological Institute, which calls itself “the only research institute in the U.S. dedicated to finding treatments to repair the brain and spinal cord,” ceased research operations on 22 May.
Exclusive: Brain and spinal cord institute halts research, citing funding problems
The Burke Neurological Institute, which calls itself “the only research institute in the U.S. dedicated to finding treatments to repair the brain and spinal cord,” ceased research operations on 22 May.
When autistic kids grow up, Chapter 1: Those people
What leads an autism researcher to publish an intentionally inflammatory paper accusing the NIH of discrimination?
When autistic kids grow up, Chapter 1: Those people
What leads an autism researcher to publish an intentionally inflammatory paper accusing the NIH of discrimination?
Supported by a $40 million NIH grant, Yale brain shuttle technology raises questions
Yale University claims its STEP platform might be able to deliver gene-editing tools into the brain via multiple routes. Researchers are eager to see more.
Supported by a $40 million NIH grant, Yale brain shuttle technology raises questions
Yale University claims its STEP platform might be able to deliver gene-editing tools into the brain via multiple routes. Researchers are eager to see more.